Abstract
Non-small cell lung cancer (NSCLC) with brain metastases (BM) is a challenging clinical issue with poor prognosis. Studies conducted with paired molecular analyses of BM and primary tumors have revealed clonal evolution and substantial differences in gene expression. No data exist regarding extensive molecular analysis of cerebrospinal fluid (CSF) and its correlation to different compartments.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
